Browse all penny stock articles in the Biotech category.
Biotech Stocks To Buy? Sanofi-Aventis (NYSE-SNY) now has approval from the board of directors to offer as much as $70 per share for Genzyme (NASDAQ:GENZ). This equals roughly $18.7 billion for the transaction. Last week…
Radient Pharmaceuticals Corporation (AMEX:RPC) We hope that everyone is enjoying their summer. We have not come out with a profile in a while because the markets have been turbulent. We have been seeing them bounce bac…
Another Way to Play Genzyme (GENZ) Biotech company Genzyme ( NASDAQ:GENZ ) was the subject of takeover rumors. CNBC’s David Faber broke the story on a possible hostile takeover bid from Sanofi-Aventis (SNY-NYSE). Shares …